Platelet Phenotype and Function Changes With Increasing Duration of Extracorporeal Membrane Oxygenation

Area of Science:

• Pediatric critical care medicine
• Hematology
• Cardiopulmonary bypass

Background:

• Extracorporeal membrane oxygenation (ECMO) is a life-support measure for critically ill neonates and children.
• Platelet dysfunction is a known complication during ECMO, but its specific pathophysiology remains incompletely understood.
• Understanding these changes is crucial for managing bleeding and thrombotic complications.

Purpose of the Study:

• To investigate the changes in platelet function and expression during pediatric ECMO.
• To identify potential markers associated with bleeding or thrombotic events in this patient population.

Main Methods:

• Prospective observational study involving 87 pediatric patients undergoing ECMO.
• Arterial blood samples were analyzed using flow cytometry on days 1, 2, and 5 of ECMO.
• Platelet markers including fibrinogen receptor expression, von Willebrand Factor expression, and response to agonists were measured.

Main Results:

• Platelet fibrinogen receptor expression decreased significantly from day 2 to day 5 of ECMO (p=0.0005).
• Von Willebrand Factor expression increased (p=0.0459), while platelet response to agonists (P-selectin, PAC-1, CD63 binding) decreased significantly over time (p<0.0022).
• 48% of patients experienced major bleeding, and 14% had thrombotic events during ECMO.

Conclusions:

• Platelet response diminishes over the course of ECMO, which may contribute to bleeding complications.
• These findings highlight the dynamic changes in platelet pathophysiology during pediatric ECMO.
• Monitoring specific platelet markers could aid in the early detection and prediction of bleeding and thrombosis in ECMO patients.